PMID- 32664386 OWN - NLM STAT- MEDLINE DCOM- 20210308 LR - 20210308 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 12 IP - 7 DP - 2020 Jul 10 TI - Srebp-1c/Fgf21/Pgc-1alpha Axis Regulated by Leptin Signaling in Adipocytes-Possible Mechanism of Caloric Restriction-Associated Metabolic Remodeling of White Adipose Tissue. LID - 10.3390/nu12072054 [doi] LID - 2054 AB - Caloric restriction (CR) improves whole body metabolism, suppresses age-related pathophysiology, and extends lifespan in rodents. Metabolic remodeling, including fatty acid (FA) biosynthesis and mitochondrial biogenesis, in white adipose tissue (WAT) plays an important role in the beneficial effects of CR. We have proposed that CR-induced mitochondrial biogenesis in WAT is mediated by peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), which is transcriptionally regulated by sterol regulatory element-binding protein 1c (SREBP-1c), a master regulator of FA biosynthesis. We have also proposed that the CR-associated upregulation of SREBP-1 and PGC-1alpha might result from the attenuation of leptin signaling and the upregulation of fibroblast growth factor 21 (FGF21) in WAT. However, the detailed molecular mechanisms remain unclear. Here, we interrogate the regulatory mechanisms involving leptin signaling, SREBP-1c, FGF21, and PGC-1alpha using Srebp-1c knockout (KO) mice, mouse embryonic fibroblasts, and 3T3-L1 adipocytes, by altering the expression of SREBP-1c or FGF21. We show that a reduction in leptin signaling induces the expression of proteins involved in FA biosynthesis and mitochondrial biogenesis via SREBP-1c in adipocytes. The upregulation of SREBP-1c activates PGC-1alpha transcription via FGF21, but it is unlikely that the FGF21-associated upregulation of PGC-1alpha expression is a predominant contributor to mitochondrial biogenesis in adipocytes. FAU - Kobayashi, Masaki AU - Kobayashi M AUID- ORCID: 0000-0002-0985-0322 AD - Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. FAU - Uta, Seira AU - Uta S AD - Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. FAU - Otsubo, Minami AU - Otsubo M AD - Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. FAU - Deguchi, Yusuke AU - Deguchi Y AD - Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. FAU - Tagawa, Ryoma AU - Tagawa R AD - Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. FAU - Mizunoe, Yuhei AU - Mizunoe Y AUID- ORCID: 0000-0001-6716-1544 AD - Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan. FAU - Nakagawa, Yoshimi AU - Nakagawa Y AUID- ORCID: 0000-0001-8710-5232 AD - Division of Complex Biosystem Research, Department of Research and Development, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan. FAU - Shimano, Hitoshi AU - Shimano H AUID- ORCID: 0000-0002-5562-5572 AD - Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan. AD - Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Ibaraki 305-8575, Japan. AD - AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo 100-1004, Japan. FAU - Higami, Yoshikazu AU - Higami Y AD - Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. AD - Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. LA - eng GR - Grants-in-Aid for Scientific Research (B) (No. 17H02179)/Japan Society for the Promotion of Science/ PT - Journal Article DEP - 20200710 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 RN - 0 (Fatty Acids) RN - 0 (Leptin) RN - 0 (Sterol Regulatory Element Binding Protein 1) RN - 0 (Transcription Factors) RN - 0 (fibroblast growth factor 21) RN - 0 (peroxisome-proliferator-activated receptor-gamma coactivator-1) RN - 62031-54-3 (Fibroblast Growth Factors) SB - IM MH - 3T3-L1 Cells MH - Adipocytes/*metabolism MH - Adipose Tissue, White/*metabolism MH - Animals MH - Caloric Restriction/*methods MH - Fatty Acids/metabolism MH - Fibroblast Growth Factors/*metabolism MH - Leptin/metabolism MH - Lipogenesis MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Mitochondria/metabolism MH - Organelle Biogenesis MH - Sterol Regulatory Element Binding Protein 1/*metabolism MH - Transcription Factors/*metabolism MH - Up-Regulation PMC - PMC7400870 OTO - NOTNLM OT - adipocyte OT - caloric restriction OT - fatty acid biosynthesis OT - mitochondrial biogenesis COIS- All authors declare no conflict of interest. EDAT- 2020/07/16 06:00 MHDA- 2021/03/09 06:00 PMCR- 2020/07/01 CRDT- 2020/07/16 06:00 PHST- 2020/06/06 00:00 [received] PHST- 2020/07/04 00:00 [revised] PHST- 2020/07/08 00:00 [accepted] PHST- 2020/07/16 06:00 [entrez] PHST- 2020/07/16 06:00 [pubmed] PHST- 2021/03/09 06:00 [medline] PHST- 2020/07/01 00:00 [pmc-release] AID - nu12072054 [pii] AID - nutrients-12-02054 [pii] AID - 10.3390/nu12072054 [doi] PST - epublish SO - Nutrients. 2020 Jul 10;12(7):2054. doi: 10.3390/nu12072054.